Ricardo Giscombe

2.1k citations
41 papers · 1.7k indexed · h-index 23
Topics
Myasthenia Gravis and Thymoma (13 papers)T-cell and B-cell Immunology (12 papers)Vasculitis and related conditions (10 papers)

In The Last Decade

Ricardo Giscombe

41 papers receiving 1.7k citations

Peers

Ricardo Giscombe
Comparison fields: 5 of 75
  • Immunology 1.1k
  • Oncology 415
  • Genetics 323
  • Pulmonary and Respiratory Medicine 301
  • Rheumatology 231
Replace Grace M. Thomas with:
Grace M. Thomas United States
Nathalie Cloutier Canada
Elvira Favoino Italy
K Kaushansky United States
Kazuma Ikeda Japan
Beverly W. Baron United States
Keiko Yoshimoto Japan
Stella Arelaki Greece
Raymond A. Kempf United States
MA Moore United States
Ricardo Giscombe relative to Grace M. Thomas United States Grace M. Thomas's profile →
Citations per field
00.5×3.4×
Grace M. Thomas · 1×
Citations per year

Countries citing papers authored by Ricardo Giscombe

Since Specialization
Citations

This map shows the geographic impact of Ricardo Giscombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Giscombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Giscombe more than expected).

Fields of papers citing papers by Ricardo Giscombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Giscombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Giscombe. The network helps show where Ricardo Giscombe may publish in the future.

Co-authorship network of co-authors of Ricardo Giscombe

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Giscombe. A scholar is included among the top collaborators of Ricardo Giscombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Giscombe. Ricardo Giscombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 29
2 64
3 16
4 273
5 10
6 172
7 81
8 122
9 35
10 70
11 18
12 65
13 24
14 6
15 45
16 23
17 13
18 28
19 10
20 13

About Ricardo Giscombe

Ricardo Giscombe is a scholar working on Immunology, Neurology and Immunology and Allergy, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (13 papers), T-cell and B-cell Immunology (12 papers) and Vasculitis and related conditions (10 papers). The work is most often cited by research in Immunology (1.1k citations), Rheumatology (231 citations) and Oncology (415 citations). Ricardo Giscombe has collaborated with scholars based in Sweden, China and United Kingdom. Frequent co-authors include Ann Kari Lefvert, Ritva Pirskanen, DeRen Huang, Xiongbiao Wang, Ann‐Kari Lefvert, Xinyu Zhao, Ming Gu, Yuping Sun, Yunshan Wang and Jianqiang Zhao. Their work appears in journals such as Blood, Annals of the New York Academy of Sciences and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026